|
MDH1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.97279999961609E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.15400000003196E-06 |
| Normal-vs-Stage2 |
2.414200E-01 |
| Normal-vs-Stage3 |
8.845500E-02 |
| Normal-vs-Stage4 |
9.756000E-04 |
| Stage1-vs-Stage2 |
1.918010E-01 |
| Stage1-vs-Stage3 |
2.453400E-01 |
| Stage1-vs-Stage4 |
8.180200E-01 |
| Stage2-vs-Stage3 |
8.275000E-01 |
| Stage2-vs-Stage4 |
2.482000E-01 |
| Stage3-vs-Stage4 |
2.847400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.44930000018407E-07 |
| Normal-vs-AfricanAmerican |
1.556970E-04 |
| Normal-vs-Asian |
9.250000E-01 |
| Caucasian-vs-AfricanAmerican |
7.012600E-01 |
| Caucasian-vs-Asian |
4.234800E-01 |
| AfricanAmerican-vs-Asian |
4.689400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.8849000005261E-07 |
| Normal-vs-Female |
3.115900E-03 |
| Male-vs-Female |
1.124220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.301540E-03 |
| Normal-vs-Extreme_Weight |
6.16220000027035E-07 |
| Normal-vs-Obese |
1.077700E-03 |
| Normal-vs-Extreme_Obese |
8.527600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.779200E-01 |
| Normal_Weight-vs-Obese |
9.556400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.379220E-01 |
| Extreme_Weight-vs-Obese |
5.451600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.554400E-02 |
| Obese-vs-Extreme_Obese |
1.758810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.505900E-02 |
| Normal-vs-Age(41-60Yrs) |
8.57920000041368E-07 |
| Normal-vs-Age(61-80Yrs) |
3.76340000000086E-05 |
| Normal-vs-Age(81-100Yrs) |
3.994400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.781400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.650000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.600600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.199400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.078800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.611600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.4347999716976E-09 |
| Normal-VS-Type2 PRCC |
6.542000E-01 |
| Normal-VS-KIRP CIMP |
6.41249999988602E-07 |
| Normal-VS-Unclassified PRCC |
1.627970E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.69949999999841E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.928630E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.051000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.76550000000098E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
4.955300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
4.630300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.305700E-02 |
| Normal-vs-N1 |
1.65139999996899E-06 |
| Normal-vs-N2 |
3.521700E-03 |
| N0-vs-N1 |
5.840300E-02 |
| N0-vs-N2 |
4.095800E-01 |
| N1-vs-N2 |
7.997200E-01 |
|
|
